XGN - Pendapatan operasional sadurunge ngurangi amortisasi exagen.com

Logo perusahaan publik exagen.com (XGN)

Exagen Inc. generates revenue through the implementation of unique laboratory tests designed to identify complex inflammatory pathologies. The company's estimated EBITDA reflects actual cash flow, while 0.00 captures the current state of the parameter. Growth is driven by the rollout of AVISE genomic tests, although final profitability is constrained by strict insurance reimbursement policies and limited pricing power.

Bathi operasional EBITDA: Exagen (XGN) kanggo 23.11.2025 - 12.11.2026

Exagen (XGN) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Bagan bursa Exagen Inc|XGN - Prakiraan konsensus analis
- statistik kapitalisasi pasar:
Kapitalisasi pasar Exagen Inc.|XGN - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Aset Bersih saben Saham Exagen Inc.|XGN - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku exagen.com|XGN - Gunggung Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Rasio Utang marang Ekuitas Exagen Inc.|XGN - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Exagen Inc|XGN - Gunggung utang perusahaan|Utang marang aset resik Exagen Inc.|XGN - Utang jangka dawa perusahaan|Utang jangka cendhak Exagen Inc.|Rasio likuiditas darurat exagen.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
XGN - Penghasilan resik|Penghasilan resik sing dikarepake Exagen Inc.|XGN - Pangali P/E|Kapitalisasi marang proyeksi bathi Exagen Inc|XGN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Exagen Inc.|XGN - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Exagen Inc.|XGN - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan exagen.com|XGN - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Exagen Inc.
Ringkesan analitik perusahaan:XGN, Exagen Inc.
Barang unggulan Exagen

Investors are assessing the resilience of Exagen Inc. (XGN) through operating cash flow, excluding the impact of depreciation and taxes to identify the net scaling rate of the business. An analysis of historical EBITDA_Co data, with a current value of 0.00, confirms the efficiency of cloud outsourcing for medical data storage, where infrastructure cost optimization and strict SLAs translate directly into operating profit growth.

Karo sapa Exagen Inc. saingan

Pendapatan operasional sadurunge ngurangi amortisasi Agilent Corp (A)|Quest Diagnostics - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi illumina.com ILMN|Exact Sciences Corporation (EXAS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RVTY - Pendapatan operasional sadurunge ngurangi amortisasi|BIO (Bio-Rad Laboratories Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Anbio Corp NNNN|Bathi operasional sadurunge ngurangi amortisasi SHC (Sotera Health Company)|quidel.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA OPK (OPKO Health)|Bathi operasional EBITDA CareDx Corp CDNA|Maravai LifeSciences Corp - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Fulgent (FLGT)|LAB: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi cytekbio.com (CTKB)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OraSure|Bathi operasional sadurunge amortisasi MDXH (MDxHealth S.A.)|Bathi operasional sadurunge ngurangi amortisasi LUCD (Lucid Diagnostics Inc)|PRE (prenetics.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA IMDX (Insight Molecular Diagnostics Inc)|Pendapatan operasional sadurunge ngurangi amortisasi Trinity Biotech PLC (TRIB)|PRPH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AIMD (Ainos Inc) - Bathi operasional sadurunge amortisasi|CODX: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Heart Test Labs|Bathi operasional sadurunge ngurangi amortisasi BMRA|Cardio Diagnostics Holdings, Inc. (CDIO) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi ONCO (Onconetix)|Virax Biolabs Group Limited - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA BJDX (Bluejay)|Bathi operasional sadurunge potongan amortisasi Aspira Women's Health Inc|AXDX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CNTG (Centogene) - Bathi operasional sadurunge amortisasi|enzo.com (ENZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Fresh2 Group|GENE (Genetic Technologies Ltd) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi 23andMe Inc ME|Bathi operasional EBITDA PMD